Skip to main content
Clinical Trials/NCT00554242
NCT00554242
Completed
Not Applicable

Chronic Study of the Effect of Grape Seed Extract Plus Ascorbic Acid on Endothelial Function in Patients With Coronary Artery Disease

Boston University1 site in 1 country40 target enrollmentJuly 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
Boston University
Enrollment
40
Locations
1
Primary Endpoint
Brachial artery flow-mediated dilation
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

A pilot study of 15 subjects will be conducted to confirm an acute effect of grape seed extract on endothelial function. We then will perform a a randomized, double blind, placebo controlled crossover study designed to investigate the benefit of grape seed extract/vitamin C treatment on endothelial function. Participants (n=40) will take a food supplement containing 450 mg of grape seed extract and 1500 mg of vitamin C or matching placebo for four weeks and then cross over to the alternative treatment (active supplement or placebo) for four weeks. We will examine endothelial function before and after each of the two treatment periods. The study will provide information about the vascular effects of these compounds.

Registry
clinicaltrials.gov
Start Date
July 2007
End Date
December 2008
Last Updated
16 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Coronary artery disease

Exclusion Criteria

  • Pregnancy
  • Clinical history of other major illness including end-stage cancer, renal failure, hepatic failure, gastrointestinal disorders that may impair absorption, or other conditions that in the opinion of the principal investigator make a clinical study inappropriate.
  • Treatment with an investigational new drug within the last 30 days.
  • History of a psychological illness or condition such as to interfere with the subject's ability to understand the requirements of the study.
  • Vitamin E, Vitamin C, and beta carotene, lipoic acid, and other food or herbal supplements within 1 month of enrollment.

Outcomes

Primary Outcomes

Brachial artery flow-mediated dilation

Time Frame: 1 month

Secondary Outcomes

  • Fingertip Pulse Amplitude Tonometry(1 month)
  • Carotid-femoral pulse wave velocity(1 month)
  • Serum markers of inflammation(1 month)

Study Sites (1)

Loading locations...

Similar Trials